Jennison Associates’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-26,840
| Closed | -$443K | – | 650 |
|
|
2018
Q3 | $443K | Sell |
26,840
-334
| -1% | -$5.51K | ﹤0.01% | 637 |
|
|
2018
Q2 | $380K | Sell |
27,174
-968
| -3% | -$13.5K | ﹤0.01% | 637 |
|
|
2018
Q1 | $311K | Buy |
+28,142
| New | +$311K | ﹤0.01% | 627 |
|
|
2017
Q3 | – | Sell |
-18,200
| Closed | -$261K | – | 651 |
|
|
2017
Q2 | $261K | Buy |
18,200
+69
| +0.4% | +$990 | ﹤0.01% | 624 |
|
|
2017
Q1 | $383K | Sell |
18,131
-764
| -4% | -$16.1K | ﹤0.01% | 612 |
|
|
2016
Q4 | $532K | Buy |
18,895
+4,470
| +31% | +$126K | ﹤0.01% | 660 |
|
|
2016
Q3 | $386K | Buy |
14,425
+932
| +7% | +$24.9K | ﹤0.01% | 610 |
|
|
2016
Q2 | $228K | Buy |
+13,493
| New | +$228K | ﹤0.01% | 616 |
|
|
2016
Q1 | – | Sell |
-367,021
| Closed | -$8.43M | – | 610 |
|
|
2015
Q4 | $8.43M | Buy |
367,021
+11,023
| +3% | +$253K | 0.01% | 480 |
|
|
2015
Q3 | $7.13M | Buy |
355,998
+2,635
| +0.7% | +$52.8K | 0.01% | 514 |
|
|
2015
Q2 | $10.2M | Buy |
+353,363
| New | +$10.2M | 0.01% | 503 |
|